Jove
Visualize
Contact Us

Related Experiment Videos

Noncompliance in schizophrenia.

I E Babiker

    Psychiatric Developments
    |January 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Schizophrenia treatment compliance is often underestimated, with existing models from physical medicine being inadequate. Behavioral interventions show promise over education for improving neuroleptic adherence in schizophrenia patients.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Object-name selection in psychiatric patients before and after neuroleptic therapy.

    Journal of psychopharmacology (Oxford, England)·2012
    Same author

    Do psychiatric patients know what is good for them?

    Journal of the Royal Society of Medicine·1993
    Same author

    How useful is riboflavin as a tracer of medication compliance?

    Journal of behavioral medicine·1989
    Same author

    The perception of visual ambiguous figures in schizophrenia and Parkinson's disease.

    International clinical psychopharmacology·1988
    Same author

    Rehabilitation in psychiatry.

    British journal of hospital medicine·1987
    Same author

    Comparative efficacy of long-acting depot and oral neuroleptic medications in preventing schizophrenic recidivism.

    The Journal of clinical psychiatry·1987
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies

    Area of Science:

    • Psychiatry
    • Clinical Psychology
    • Pharmacology

    Background:

    • Neuroleptic treatment is central to schizophrenia management.
    • High rates of noncompliance (up to 50%) are reported, likely underestimated.
    • Existing compliance models from physical medicine are often unsuitable for schizophrenia due to altered illness perception.

    Purpose of the Study:

    • To review compliance research in schizophrenia, particularly concerning neuroleptic treatment.
    • To evaluate factors contributing to noncompliance in schizophrenia.
    • To propose a theoretical model and research strategy for schizophrenia compliance.

    Main Methods:

    • Literature review of compliance research in schizophrenia.
    • Discussion of methodological challenges in assessing compliance.

    Related Experiment Videos

  • Evaluation of existing compliance models and their applicability.

    • Main Results:

    • Reported noncompliance rates are likely underestimates.
    • Standard compliance models are of questionable relevance.
    • Behavioral interventions may be more effective than educational strategies.

    Conclusions:

    • Schizophrenia compliance requires tailored theoretical models and research.
    • Behavioral interventions warrant further investigation for managing noncompliance.
    • Methodological rigor in compliance assessment is crucial for future research.